title: Parathyroid tumor development involves deregulation of homeobox genes.
abstract: Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant syndrome caused by mutations in the MEN1 tumor suppressor gene. Loss of the functional second copy of the MEN1 gene causes individuals to develop multiple endocrine tumors, primarily affecting the parathyroid, pituitary, and pancreas. While it is clear that the protein encoded by MEN1, menin, suppresses endocrine tumors, its biochemical functions and direct downstream targets remain unclear. Recent studies have suggested that menin may act as a scaffold protein to coordinate gene transcription, and that menin is an oncogenic cofactor for homeobox (HOX) gene expression in hematopoietic cancer. The role of HOX genes in adult cell differentiation is still obscure, but growing evidence suggests that they may play important roles in the development of cancer. Therefore, we hypothesized that specific HOX genes were regulated by menin in parathyroid tumor development. Utilizing quantitative TaqMan RT-PCR, we compared expression profiles of the 39 HOX genes in human familial MEN1 (fMEN1) parathyroid tumors and sporadic parathyroid adenomas with normal samples. We identified a large set of 23 HOX genes whose deregulation is specific for fMEN1 parathyroid tumors, and only 5 HOX genes whose misexpression are specific for sporadic parathyroid tumor development. These findings provide the first evidence that loss of the MEN1 tumor suppressor gene is associated with deregulation of specific HOX gene expression in the development of familial human parathyroid tumors. Our results strongly reinforce the idea that abnormal expression of developmental HOX genes can be critical in human cancer progression.
authors.affiliation: Tumor Angiogenesis Section, Surgery Branch, National Cancer Institute, NIH, Bethesda, MD 20892, USA.
authors.forename: H-C Jennifer
authors.initials: HC
authors.lastname: Shen
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Rosen
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Yang
authors.forename: Sharon A
authors.initials: SA
authors.lastname: Savage
authors.forename: A Lee
authors.initials: AL
authors.lastname: Burns
authors.forename: Carmen M
authors.initials: CM
authors.lastname: Mateo
authors.forename: Sunita K
authors.initials: SK
authors.lastname: Agarwal
authors.forename: Settara C
authors.initials: SC
authors.lastname: Chandrasekharappa
authors.forename: Allen M
authors.initials: AM
authors.lastname: Spiegel
authors.forename: Francis S
authors.initials: FS
authors.lastname: Collins
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Marx
authors.forename: Steven K
authors.initials: SK
authors.lastname: Libutti
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D005801:Genes, Homeobox / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D018761:Multiple Endocrine Neoplasia Type 1 / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D009154:Mutation / Q000235:genetics*; D010282:Parathyroid Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000235:genetics* / Q000378:metabolism; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: C105373:MEN1 protein, human; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger